Stockscreener 앱 받기
1.21
7.63%
-0.10
시간 외 거래:
1.16
-0.05
-4.13%
전일 마감가:
$1.31
열려 있는:
$1.26
하루 거래량:
1.56M
Relative Volume:
2.10
시가총액:
$55.33M
수익:
$19.94M
순이익/손실:
$-37.37M
주가수익비율:
-1.1635
EPS:
-1.04
순현금흐름:
$-33.38M
1주 성능:
-25.31%
1개월 성능:
-40.98%
6개월 성능:
+33.75%
1년 성능:
-46.46%
1일 변동 폭
$1.1601
$1.30
1주일 범위
$1.08
$1.62
52주 변동 폭
$0.595
$2.52
웨어울프 테라 Stock (HOWL) Company Profile
명칭
Werewolf Therapeutics Inc
전화
617-952-0555
주소
200 TALCOTT AVENUE, WATERTOWN
HOWL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.21 | 59.90M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
웨어울프 테라 Stock (HOWL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-03 | 개시 | JMP Securities | Mkt Outperform |
| 2023-08-24 | 개시 | Wedbush | Outperform |
| 2023-06-06 | 재개 | Jefferies | Buy |
| 2021-09-10 | 개시 | BofA Securities | Buy |
| 2021-05-25 | 개시 | Evercore ISI | Outperform |
| 2021-05-25 | 개시 | H.C. Wainwright | Buy |
| 2021-05-25 | 개시 | Jefferies | Buy |
| 2021-05-25 | 개시 | SVB Leerink | Outperform |
모두보기
웨어울프 테라 주식(HOWL)의 최신 뉴스
Werewolf Therapeutics Reports Q3 2025 Financial Results - TipRanks
Luke Evnin Sells 55,795 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - MarketBeat
Werewolf Therapeutics (NASDAQ:HOWL) Director Luke Evnin Sells 60,369 Shares - MarketBeat
Bioventures 2014 L.P. Mpm Sells 86,936 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - MarketBeat
Insider Selling: Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Sells 114,044 Shares of Stock - MarketBeat
Ansbert Gadicke Sells 86,936 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - MarketBeat
Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Ansbert Gadicke Sells 114,044 Shares - MarketBeat
Insider Selling: Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Sells 94,063 Shares of Stock - MarketBeat
Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Sells $121,341.27 in Stock - MarketBeat
Werewolf Therapeutics Narrows Losses And Wins FDA Fast Track Nod - Finimize
Werewolf Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Werewolf Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - Investing News Network
Werewolf Therapeutics Q3 net loss narrows on lower R&D expenses - MarketScreener
Werewolf Therapeutics Inc. stock trend forecastQuarterly Profit Review & Free Expert Approved Momentum Trade Ideas - newser.com
Advanced analytics toolkit walkthrough for Werewolf Therapeutics Inc.Market Risk Summary & Fast Gain Swing Alerts - newser.com
Is Werewolf Therapeutics Inc. reversing from oversold territory2025 Top Decliners & Proven Capital Preservation Methods - newser.com
How Werewolf Therapeutics Inc. stock performs after earningsPortfolio Performance Summary & Step-by-Step Swing Trade Plans - newser.com
Analyzing recovery setups for Werewolf Therapeutics Inc. investorsStop Loss & Capital Efficient Trade Techniques - newser.com
Visual trend scoring systems applied to Werewolf Therapeutics Inc.July 2025 Decliners & Accurate Technical Buy Alerts - newser.com
How to read the order book for Werewolf Therapeutics Inc.July 2025 Macro Moves & Community Supported Trade Ideas - newser.com
Werewolf therapeutics director Evnin sells $251k in HOWL stock By Investing.com - Investing.com Canada
Werewolf therapeutics director Evnin sells $251k in HOWL stock - Investing.com
A History of Outperforming Analyst Forecasts and Beating the Odds: Werewolf Therapeutics Inc (HOWL) - setenews.com
Is Werewolf Therapeutics Inc. stock bottoming outJuly 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com
What MACD signals say about Werewolf Therapeutics Inc.Global Markets & AI Driven Price Predictions - newser.com
Will Werewolf Therapeutics Inc. stock recover faster than marketQuarterly Trade Review & Verified Entry Point Detection - newser.com
Will Werewolf Therapeutics Inc. price bounce be sustainable2025 Top Decliners & Entry Point Confirmation Alerts - newser.com
Will Werewolf Therapeutics Inc. stock outperform growth indexesWeekly Trade Analysis & Weekly High Conviction Ideas - newser.com
Werewolf Therapeutics Inc. stock trendline breakdownJuly 2025 Retail & Technical Pattern Alert System - newser.com
Identifying reversal signals in Werewolf Therapeutics Inc.Price Action & AI Driven Stock Movement Reports - newser.com
Predicting Werewolf Therapeutics Inc. trend using moving averagesEntry Point & Risk Managed Investment Signals - newser.com
Werewolf Therapeutics Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
Werewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Will Werewolf Therapeutics Inc. stock reach all time highs in 2025Weekly Profit Analysis & Weekly High Return Forecasts - newser.com
웨어울프 테라 (HOWL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):